American Century Companies Inc. lowered its position in shares of Agilent Technologies Inc (NYSE:A) by 18.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,521,222 shares of the medical research company’s stock after selling 776,414 shares during the period. American Century Companies Inc.’s holdings in Agilent Technologies were worth $235,816,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. TimesSquare Capital Management LLC bought a new stake in Agilent Technologies during the third quarter valued at about $58,550,000. Janus Henderson Group PLC boosted its position in Agilent Technologies by 2,135.0% during the second quarter. Janus Henderson Group PLC now owns 836,051 shares of the medical research company’s stock valued at $49,587,000 after purchasing an additional 798,643 shares in the last quarter. Bank of Montreal Can boosted its position in Agilent Technologies by 187.3% during the fourth quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock valued at $49,693,000 after purchasing an additional 483,721 shares in the last quarter. Wells Fargo & Company MN boosted its position in Agilent Technologies by 27.6% during the third quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock valued at $140,244,000 after purchasing an additional 473,047 shares in the last quarter. Finally, Koch Industries Inc. bought a new stake in Agilent Technologies during the second quarter valued at about $438,000.
Shares of Agilent Technologies Inc (A) opened at $68.22 on Tuesday. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. Agilent Technologies Inc has a twelve month low of $48.96 and a twelve month high of $75.00. The company has a market capitalization of $21,960.00, a PE ratio of 32.64, a P/E/G ratio of 2.15 and a beta of 1.28.
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd were issued a dividend of $0.149 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date was Friday, December 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.87%. Agilent Technologies’s payout ratio is 28.71%.
A has been the subject of several recent analyst reports. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a report on Tuesday, October 31st. Barclays reissued a “buy” rating and issued a $74.00 price target on shares of Agilent Technologies in a report on Monday, January 8th. Robert W. Baird reissued a “buy” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Friday, October 20th. Evercore ISI initiated coverage on Agilent Technologies in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 price target for the company. Finally, ValuEngine downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus price target of $69.25.
In related news, CEO Michael R. Mcmullen sold 21,850 shares of Agilent Technologies stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the completion of the sale, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $24,351,525. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 43,703 shares of Agilent Technologies stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $70.00, for a total value of $3,059,210.00. Following the sale, the chief executive officer now directly owns 302,837 shares of the company’s stock, valued at approximately $21,198,590. The disclosure for this sale can be found here. Insiders have sold 219,991 shares of company stock valued at $15,468,795 in the last ninety days.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.